Maria T Cruanes

Title: Maria T Cruanes: Innovator in Pharmaceutical Formulations

Introduction

Maria T Cruanes is a distinguished inventor based in Lansdale, PA (US). She has made significant contributions to the field of pharmaceutical formulations, holding a total of 3 patents. Her work focuses on developing innovative solutions for the treatment and prevention of HIV and related conditions.

Latest Patents

Maria's latest patents include a pharmaceutical formulation containing a release rate controlling composition. This formulation is designed for oral administration in solid dosage forms and comprises an effective amount of a base salt of a compound of Formula (I) along with a release rate controlling composition. This composition includes a solubilizing agent, a gelling agent, and a water-soluble filler. The formulations are particularly suitable for inhibiting HIV integrase and for the treatment and prophylaxis of HIV infection, as well as delaying the onset of AIDS.

Another notable patent is her pharmaceutical composition containing an anti-nucleating agent. This composition is also suitable for oral administration in solid dosage forms and includes a drug compound in the form of a salt. The drug salt is characterized by its conversion to a less soluble form under certain pH conditions, along with an anti-nucleating agent to enhance its effectiveness.

Career Highlights

Maria T Cruanes is currently employed at Merck Sharp & Dohme Corporation, where she continues to advance her research in pharmaceutical sciences. Her innovative work has positioned her as a key player in the development of effective treatments for serious health conditions.

Collaborations

Throughout her career, Maria has collaborated with notable colleagues, including Agam R Sheth and Bhagwant Rege. These collaborations have further enriched her research and contributed to her success in the field.

Conclusion

Maria T Cruanes exemplifies the spirit of innovation in pharmaceutical research. Her contributions through her patents are paving the way for advancements in the treatment of HIV and related diseases.